Australia markets closed

Zivo Bioscience, Inc. (ZIVOW)

OTC Markets OTCPK - OTC Markets OTCPK Delayed price. Currency in USD
Add to watchlist
0.20000.0000 (0.00%)
At close: 11:42AM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.22
52-week change 3N/A
S&P500 52-week change 322.55%
52-week high 30.2000
52-week low 30.2000
50-day moving average 3N/A
200-day moving average 3N/A

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 5N/A
Implied shares outstanding 6N/A
Float 81.49M
% held by insiders 1N/A
% held by institutions 1N/A
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends N/A
Most-recent quarter (mrq)N/A

Profitability

Profit margin 0.00%
Operating margin (ttm)-3,571.78%

Management effectiveness

Return on assets (ttm)-422.29%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)63.37k
Revenue per share (ttm)0.03
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA N/A
Net income avi to common (ttm)-7.08M
Diluted EPS (ttm)N/A
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)138.64k
Total cash per share (mrq)0.05
Total debt (mrq)779.09k
Total debt/equity (mrq)N/A
Current ratio (mrq)0.23
Book value per share (mrq)-0.81

Cash flow statement

Operating cash flow (ttm)-5.37M
Levered free cash flow (ttm)-2.69M